🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 04272N102
- IPO
- 1/26/2024 · $18.00/share
Business: ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers.
Company Contact
- CEO
- Zhengbin (Bing) Yao
- CFO
- Barbara Carlin
- Headquarters
- 18 Campus Boulevard, Suite 100, Newtown Square, PA 19073
- Phone
- 628-277-4836
- Investor Relations
- info@arrivent.com